IVERMECTIN

Summary of the Clinical Trials Evidence for Ivermectin in COVID­19

Ivermectin, an anti-parasitic medicine whose discovery won the Nobel Prize in 2015, has proven, highly potent, anti-viral and anti- inflammatory properties in laboratory studies. In the past 4 months, numerous, con-trolled clini cal trials f rom multiple centers and countries worldwide are reporting consistent, large improvements in COVID-19 patient outcomes when treated with ivermectin.

Our comprehensive scientific review of these referenced trials on ivermectin can be found onwww.flccc.net/flccc-ivermectin-in-the-prophylaxis-and-treatment-of-covid-19/

For a quick overview, a One-page Summary of our review on ivermectin can be found onwww.flccc.net/flccc-ivermectin-summary

Body weight conversion (kg/lb) for ivermectin dose in prevention and treatment of COVID­19